Open
Register Now
Please click the following link to register with your account.

Research

 

New research partnership targets relatives of people with glaucoma

NHMRC funds the TARRGET study for three years, 2017 to 2019


 

Advances in the Medical Treatment of Glaucoma

An overview of the types of eyedrops used to halt the progression of glaucoma.


 

Glaucoma following congenital cataract surgery

Babies who have undergone cataract surgery at 3 months or younger may be at higher risk of developing glaucoma


 

Glaucoma Treatment in Pregnancy

You may need to stop or adjust medications for glaucoma when you are pregnant


 

Glaucoma Research Update: The Year in Review (2014)

Glaucoma continues to be one of the least well understood eye diseases of all – partly due to the fact that it is an umbrella term for a variety of diseases with a common endpoint and partially due to the complexity of these disease processes. However 2014 was a good year with a number of research breakthroughs – some locally based – that helped provide insights into glaucoma as a disease and as potential avenues for therapy.


 

Swimming Goggles

The risk of intraocular pressure elevation caused by wearing swimming goggles. Check out the research and the most up-to-date recommendations to minimise the risk of glaucoma worsening by using swimming goggles.


 

Is trabeculectomy still the first choice surgical procedure?

The decades-old procedure remains the gold standard of treatment for many glaucoma patients.


 

Family History and Glaucoma

What we know about glaucoma running in families. Much work has been undertaken to unravel which specific genes are involved in the various types of glaucoma and the importance of family history.


 

Improving Quality of Life for Patients

How researchers are looking to improve the day-to-day experience of people with glaucoma. Having glaucoma can impact a person’s quality of life, making them less likely to lead a happy and fulfilling life, even in the early stages of the disease.


 

Minimally Invasive Glaucoma Surgery

Lighter surgery options which look to control eye pressure with fewer side effects than traditional surgery


 

TARRGET Study Report

The Targeting At Risk Relatives of Glaucoma patients for Early diagnosis and Treatment (TARRGET) study is a partnership project between Glaucoma Australia and the Australian and New Zealand Registry of Advanced Glaucoma (based at Flinders University, Adelaide).

TARRGET aims to investigate the feasibility of offering free glaucoma screening to immediate relatives of people who have been diagnosed with advanced glaucoma.


 

The TEK Gene: Responsible for Primary Congenital Glaucoma?

Researchers identify a new genetic cause for childhood glaucoma


 

It’s okay to ask your Doctor: “Did You Wash Your Hands?”

The standards of care around handwashing for medical professionals. 

It is vital that health care providers wash their hands frequently because this can prevent the spread of bacteria and viruses that cause disease and even death in patients.


 

Methods to Improve Glaucoma Detection

Can we improve our detection of glaucoma in the early stages of development?


 

Update on Iridotomy

An Iridotomy is a surgical procedure used to treat angle-closure glaucoma. Does altering iridotomy placement reduce side effects?


 

National Eye Health Survey

Determining the nationwide prevalence and causes of vision impairment in Indigenous and non-Indigenous Australians has the potential to contribute significantly to Australian eye health knowledge.


 

The TARRGET Project – January 2017 Update

The TARRGET project (Targeting At Risk Relatives of Glaucoma patients for Early diagnosis and Treatment) is nearing completion of the pilot study phase.


 

Corneal Thickness

How does corneal thickness influence risk of developing glaucoma?


 

Early detection of glaucoma? Live imaging of ganglion cells in the retina

Live imaging of ganglion cells using adaptive optics.

A ganglion cell in the eye is a neuron (nerve) cell located near the inner surface of the retina. It receives visual information and passes this on to the brain to enable people to see.


 

When raised pressure is not glaucoma

Why do some people have raised eye pressure yet not develop glaucoma?


 

Glaucoma Research Update: The Year in Review (2015)

2015 proved to be a busy year for glaucoma research, highlighted at both the Association for Research in Vision and Ophthalmology (ARVO) meeting and the World Glaucoma Congress. In addition, one of the main outcomes was the consensus to finalise the new Asia Pacific Glaucoma Guidelines (third edition) due for launch in mid-2016, which will guide glaucoma management across the region over the next few years.


 

Researchers make Retinal Ganglion Cells from Stem Cells

Researchers at the Indiana University and Purdue University Indianapolis have taken stem cells from two different groups: patients who have an inherited form of glaucoma and subjects without glaucoma. The skin cells were then genetically reprogrammed into pluripotent stem cell (master cells), which can then become almost any type of call.

Stem Cells

This method is reported in the journal Stem Cell and may help improve glaucoma treatments, lead to medication being personalised, and help to study the underlying mechanism of glaucoma.

http://onlinelibrary.wiley.com/doi/10.1002/stem.2356/full

Oct 2016

There is a new technique that can see individual retinal ganglion cells on the human retina.

University of Pittsburgh Assistant Professor of Ophthalmology Ethan Rossi, and colleagues led by University of Rochester Dean for Research in Arts, Sciences and Engineering Professor David Williams published their study: http://www.pnas.org/content/114/3/586.abstract

This technique may help to assess the thickness of retinal nerve fibres better and in doing so prevent vision loss by detecting glaucoma and starting treatment earlier. The death of retinal ganglion cells is what causes vision loss in glaucoma.

Retinal ganglion cells

Retinal ganglion cells in a macaque, scale bar 25 microns.
Image taken by Ethan Rossi with assistance of the University of Rochester team.

Jan 2017